Following my rant about the heavy-handedness of FDA ad guidelines, the marketers of Prevacid have announced they're pulling their TV spots in favor of running more print ads featuring more disclaimers. A Prevacid spokesperson said, "'Print advertising allows consumers to take their time reviewing important risk-benefit information. Additionally, it gives us ample space to include that information.'"
Let me translate that: "when the FDA sent out those four warning letters to other pharm advertisers, we crapped our pants. Now our only hope to avoid similar FDA treatment is to load up on low-profile print ads. Pray for us."